2025年，中国经济"稳"的格局持续巩固，"进"的势头不断增强，"韧"的特性日益凸显，为世界经济增添 宝贵信心。不少外资企业持续加码投资中国市场，"看好中国"成为共识。接受本报记者采访的在华外资 企业负责人表示，2025年中央经济工作会议、"十五五"规划建议释放出中国进一步扩大开放、吸引外资 等积极信号。外企坚定继续投资中国的信心，期待更多合作共赢的机遇，为世界经济发展注入更多动 力。 "中国经济表现出显著的韧性，成为全球经济的稳定之锚" 2025年前11个月，中国全国新设立外商投资企业61207家，同比增长16.9%；11月当月新设立外商投资 企业7425家，同比增长35.3%。 毕马威日前发布的《2025年跨国企业中国展望》显示，大多数行业的跨国企业对未来3至5年在中国的收 入增长前景持更为乐观的态度，94%的受访企业表示会继续投资中国市场。"尽管面临各种挑战，中国 经济表现出显著的韧性，成为全球经济的稳定之锚。"毕马威中国客户及业务发展主管合伙人江立勤表 示，"根据调查，相较于全球经济，跨国公司对中国经济前景更为乐观。" 在施耐德电气上海普陀工厂里，机器学习支持的数字快速原型制作、智能规划与排程及生成式 ...

2025年，中国经济"稳"的格局持续巩固，"进"的势头不断增强，"韧"的特性日益凸显，为世界经济增添 宝贵信心。不少外资企业持续加码投资中国市场，"看好中国"成为共识。接受本报记者采访的在华外资 企业负责人表示，2025年中央经济工作会议、"十五五"规划建议释放出中国进一步扩大开放、吸引外资 等积极信号。外企坚定继续投资中国的信心，期待更多合作共赢的机遇，为世界经济发展注入更多动 力。 "全球创新的源头和驱动增长的核心引擎" 2025年前11个月，电子商务服务业、医疗仪器设备及器械制造业、航空航天器及设备制造业实际使用外 资同比分别增长127%、46.5%、41.9%。外资加速流向高技术产业，彰显了中国新质生产力与科技创新 生态的澎湃动能。 在施耐德电气上海普陀工厂里，机器学习支持的数字快速原型制作、智能规划与排程及生成式人工智能 运维等，缩短了67%的订单生产交付时间，人均生产效率提升82%。施耐德电气执行副总裁、中国及东 亚区总裁尹正表示："在中国，'人工智能+'政策结合雄厚的产业基础、多元的应用场景、丰富的创新资 源，催生了快速崛起的人工智能产业集群，使中国成为全球人工智能产业发展高地，也成为施耐德电气 ...

Core Viewpoint - Lumexa Imaging Holdings is set to raise $463 million by issuing 25 million shares at a price of $18.50 each, with a market capitalization of $1.8 billion post-listing [1] Company Overview - Lumexa Imaging Holdings is a national provider of outpatient diagnostic imaging services in the United States, operating 184 imaging centers across 13 states through wholly-owned sites and joint ventures with healthcare systems [1] - The company offers a range of advanced and routine imaging equipment, including MRI, CT, PET scans, X-rays, ultrasounds, and mammography [1] Financial Projections - For the 12 months ending September 30, 2025, Lumexa is projected to achieve sales of $1 billion [1] Listing Details - The company plans to list on NASDAQ under the ticker symbol "LMRI" [1] - The joint bookrunners for this offering include Barclays, JPMorgan, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, and Raymond James [1]

张英 医疗反腐风暴渐渐平息，医疗设备经销商却未能放松，他们面临更大的考验——集采。 11月，多位医疗设备经销商找到张震，想聊聊转型的可能。几年前，当安徽、福建率先开展医疗设备省 级集采时，张震就决定陆续放弃医疗设备经销业务，现在已转型到投资行业。 医疗设备集采最初于2020年开始在安徽、福建施行，不过此后几年跟进的省份较少，直至近一年来情况 出现变化——据经济观察报统计，全国至少已有14个省份开展医疗设备集采。 医疗设备包括常见的超声、CT、数字X线（DR）、呼吸机，也包括一般人不太了解的磁共振（MR）、 血管造影系统、手术机器人、放疗设备等。 与药品和耗材直接用于治疗患者不同，医疗设备多是医生诊断的辅助工具，相当于医生的眼睛。 患者对医疗设备的价格感知较弱，它的价格直接影响到的是医疗机构的采购成本，进而常以间接的方式 影响患者的检查等费用。 在2023年开始的医疗反腐风暴中，医疗设备采购中存在的贪腐受到高度关注。多位受访者认为，这是近 一年来多省陆续开展医疗设备集采的重要背景，未来医疗设备集采会持续扩围。 这场集采浪潮正重塑医疗设备万亿市场，那些曾价值上百万元、千万元的大块头设备在这场集采中不断 刷新最低价 ...

Core Insights - In October 2025, the total number of medical device procurement projects in Henan Province decreased to 722, but the total budget and winning bid amounts increased compared to September [1][9] - Zhengzhou Traditional Chinese Medicine Hospital led the bidding with a budget of 1.16 billion yuan, while the total bidding budget for the province reached approximately 9.06 billion yuan, reflecting a 5% increase from the previous month [2][6] Bidding Overview - The number of bidding projects in October was 453, a decrease of 29 from September, while the total bidding budget increased by 43.73 million yuan [2] - Zhengzhou accounted for nearly 50% of the total bidding projects with 220, and its bidding budget increased by over 50% to 3.75 billion yuan [4] - The top bidding projects included a 77.99 million yuan project for traditional Chinese medicine innovation and a 54.01 million yuan project for medical equipment procurement at Lankao County Hospital [6] Winning Bid Overview - The total number of winning bids in October was 269, with a total amount of approximately 6.76 billion yuan, an increase of 557.5 million yuan from September [9] - New Xiang City surpassed Zhengzhou with a winning bid total of 1.43 billion yuan, with the top project being a 82.57 million yuan MRI purchase [9][12] - The leading companies in terms of winning bid amounts included Beijing Chenxing Kangrui Technology Co., Ltd. and Shanghai Chengtai Zhide Medical Technology Development Co., Ltd. [10][12] Specific Projects - The procurement project for the Nanyang Central Hospital, which began in April, successfully concluded with a total budget of 1.32 billion yuan and a winning bid amount of 1.29 billion yuan [13] - The project included multiple batches, with the fourth batch involving a budget of 17.55 million yuan for various medical equipment [13][14] - The Nanyang Central Hospital is set to become a major regional medical center with a focus on neurology and orthopedics, with plans for 2,000 beds and 51 operating rooms [14]

Investment Rating - The industry investment rating is maintained at "Outperform" [3][52]. Core Insights - In September 2025, the total bid amount for medical devices reached 15.534 billion yuan, showing a month-on-month increase of 18% but a year-on-year decrease of 3%. The total bid amount from January to September 2025 was 125.908 billion yuan, reflecting a year-on-year growth of 42% [4][9]. Summary by Sections Medical Device Procurement Overview - The total bid amount for medical devices in September 2025 was 15.534 billion yuan, with a month-on-month increase of 18% and a year-on-year decrease of 3%. The cumulative bid amount from January to September 2025 was 125.908 billion yuan, representing a year-on-year increase of 42% [4][9]. Domestic Brands - **United Imaging**: In September 2025, the total bid amount was 836 million yuan, a year-on-year increase of 23%. From January to September 2025, the total was 7.871 billion yuan, up 55% year-on-year [5][13]. - **Myray Medical**: The total bid amount in September 2025 was 999.2 million yuan, a year-on-year increase of 14% and a month-on-month increase of 18%. The cumulative amount from January to September was 6.898 billion yuan, reflecting a year-on-year growth of 43% [17][18]. - **Kaili Medical**: The total bid amount in September 2025 was 162 million yuan, a year-on-year increase of 65%. The cumulative amount from January to September was 1.067 billion yuan, up 94% year-on-year [25][26]. - **Wandong Medical**: The total bid amount in September 2025 was 130 million yuan, a year-on-year increase of 51%. The cumulative amount from January to September was 1.066 billion yuan, reflecting a year-on-year growth of 98% [33][34]. - **Shanwaishan**: The total bid amount in September 2025 was 66 million yuan, a year-on-year increase of 25%. The cumulative amount from January to September was 349 million yuan, up 134% year-on-year [29][30]. Imported Brands - **Philips**: The total bid amount in September 2025 was 980 million yuan, a year-on-year increase of 36%. The cumulative amount from January to September was 6.701 billion yuan, reflecting a year-on-year growth of 32% [36][37]. - **Siemens**: The total bid amount in September 2025 was 1.014 billion yuan, a year-on-year increase of 8%. The cumulative amount from January to September was 8.502 billion yuan, up 42% year-on-year [40][41]. - **GE Medical**: The total bid amount in September 2025 was 1.288 billion yuan, a year-on-year increase of 6%. The cumulative amount from January to September was 9.822 billion yuan, reflecting a year-on-year growth of 36% [44][45].

Core Insights - The meeting between Changsha Flying Fish Medical Imaging Diagnosis Center and the Hunan Enterprise Culture Promotion Association aimed to explore collaboration in healthcare and corporate culture, focusing on resource sharing and member service upgrades [1][3] Group 1: Company Overview - Flying Fish Imaging has been operating in the independent third-party medical imaging diagnosis sector for six years, emphasizing its core value of "benevolence" and providing high-quality imaging diagnostic solutions for cardiovascular and cancer screenings [1][3] - The company has served over 200,000 individuals with MRI, CT, and ultrasound services, showcasing its strong clinical service experience [1] Group 2: Future Plans - The company plans to establish "Flying Fish Health Stations" across various provinces, offering a one-stop service for patients visiting Changsha, which includes consultation, accompaniment, and imaging checks without waiting [3] - There is an intention to deepen cooperation with member units in areas such as customized health check-ups and health education, aiming to create a more convenient and professional healthcare service system [3] Group 3: Collaboration and Support - The Hunan Enterprise Culture Promotion Association recognizes Flying Fish Imaging's technical strength and innovative service models, emphasizing the importance of resource sharing and mutual benefits for joint development [5] - The association will act as a bridge to facilitate cross-industry exchanges and project collaborations, proposing joint initiatives like health seminars and customized health screenings for employees [5][7] Group 4: Next Steps - A regular communication mechanism will be established between the association and Flying Fish Imaging to implement the discussed topics, aiming to inject new momentum into the development of corporate culture and healthcare in Hunan Province [7]

Investment Rating - The industry rating is maintained at "Outperform" [2] Core Insights - The medical device sector faced pressure in Q2 2025, with a decline in revenue and net profit, but signs of recovery are expected in Q3 2025 [3][11] - The overall revenue for the medical device sector in H1 2025 decreased by 7.3% year-on-year, while net profit dropped by 27.0% [11] - The bidding and procurement activities in the domestic market are recovering, with a significant increase in the total bidding amount for medical devices in H1 2025, which reached 838 billion yuan, a year-on-year growth of 64% [12][13] - Companies are increasingly focusing on international markets, with notable growth in overseas revenues for several firms [3][11] Summary by Sections 01 Medical Device Mid-Year Report Analysis - The medical device sector's overall revenue in H1 2025 was 42.397 billion yuan, with a year-on-year decline of 7.34% [10] - The gross profit margin for H1 2025 was 50.49%, slightly down from the previous year due to price pressures from domestic procurement policies [11] - The recovery of bidding activities is expected to lead to improved performance in Q3 2025 [11] 02 Segment Analysis - The bidding amount for CT machines in H1 2025 reached 114 billion yuan, a 106% increase year-on-year, indicating a strong recovery in demand [12][13] - Companies like Mindray and United Imaging reported significant growth in overseas revenues, with Mindray's international business accounting for approximately 50% of its total revenue [3][11] 03 Related Company Mid-Year Summaries - Mindray's revenue in H1 2025 was 167.43 billion yuan, down 18.45% year-on-year, but the company expects a turnaround in Q3 [45] - United Imaging's revenue grew by 12.79% to 60.16 billion yuan in H1 2025, with a focus on high-performance imaging and radiation therapy equipment [51] - Yuyue Medical reported a revenue increase of 8.16% to 46.59 billion yuan in H1 2025, driven by advancements in technology and a global strategy [68]

Core Insights - Ningbo Beilun District has transformed from a "manufacturing region" to an "intelligent manufacturing stronghold," showcasing significant achievements in industrial value-added growth and digital transformation [1][2][4] Group 1: Industrial Development - The industrial added value of above-scale enterprises in Ningbo has ranked first in Zhejiang Province for seven consecutive years, with four companies listed among China's top 500 manufacturers [1] - The district has established a complete industrial chain for new energy vehicles, housing over 800 related enterprises [3] - Key industries such as new energy vehicles, integrated circuits, and intelligent robots have shown substantial growth, contributing to the district's robust industrial foundation [4] Group 2: Emerging Industries - A new robot industrial park covering 1,413 acres is under construction, with several local enterprises investing in benchmark projects [2] - Companies like Ningbo Deyue Technology Co., Ltd. are transitioning from traditional appliance manufacturing to solar inverter production, indicating a shift towards new energy sectors [2] - The district is focusing on high-end equipment manufacturing, with companies developing intelligent manufacturing systems for drones and heavy-duty robots [2] Group 3: Innovation and Technology - The establishment of high-energy platforms, such as the Lingfeng Modern Industrial Park, aims to attract projects in artificial intelligence and humanoid robotics [6] - The integration of technology and industry is emphasized, with local enterprises leveraging their expertise in automotive components to innovate in humanoid robot manufacturing [3][6] - The district is fostering a health management industry chain that covers the entire process from screening to treatment, focusing on cutting-edge fields like neuroscience and AI in healthcare [5][6] Group 4: Business Environment - Ningbo Beilun District prioritizes optimizing the business environment as a key driver for high-quality development, facilitating technology transfer and collaboration between enterprises and research institutions [7][8] - Initiatives such as the "smart engine" for business environment optimization aim to enhance legal services, government efficiency, and resource allocation for enterprises [8] - The district is committed to deepening the integration of technological and industrial innovation, particularly in artificial intelligence, to accelerate the transformation of traditional industries [8]

Core Viewpoint - The National Healthcare Security Administration (NHSA) has initiated a standardization of pricing for radiological examination services, aiming to reduce unreasonable regional disparities in pricing by integrating fee items and unifying pricing across provinces [1][5]. Pricing Adjustments - Since 2025, multiple provinces have adjusted the pricing standards for common imaging examinations such as CT, MRI, and X-ray. For instance, in Shaanxi Province, new regulations have led to significant price reductions for high-cost examinations like PET/CT, with prices dropping from over 4200 yuan to 2450 yuan, a reduction of over 40% [2][3][4]. - The new pricing system categorizes examination items into seven major categories, including X-ray, CT, MRI, and PET/CT, with a total of 233 old items being consolidated into 26 new ones [3][6]. Digital Transformation - The new regulations eliminate the bundling of physical film with examination pricing, allowing patients to access cloud-based imaging conveniently. If public medical institutions do not provide compliant digital imaging services, they will incur a price reduction of 5 yuan per examination [4][7]. Market Dynamics - The price adjustments are closely linked to the centralized procurement of medical equipment and the accelerated domestic substitution of imported devices. The price of CT machines has decreased significantly over the past decade, with prices dropping from 5-8 million yuan in 2015 to 3-5 million yuan today, a reduction of approximately 40% [7][8]. - The domestic market for CT equipment has seen a 50% localization rate, although domestically produced devices account for only 35% of sales revenue due to their lower prices [7]. Financial Implications - The annual costs associated with film and repeated examinations in resource-rich provinces could reach up to 50 billion yuan. If these efficiencies are implemented nationwide, it could free up over 80 billion yuan annually for healthcare funding [8]. Future Outlook - The new pricing rules focus on examination effectiveness rather than equipment parameters, promoting a more rational pricing structure. The guidelines will also support the integration of AI-assisted diagnostics without imposing additional costs on patients [8].